{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:12:45Z","timestamp":1783901565231,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01377-w","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:43:49Z","timestamp":1778053429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Allergic disease as a risk factor for Parkinson\u2019s disease: a possible role of eosinophil"],"prefix":"10.1038","volume":"12","author":[{"given":"Hee Jin","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Hyeon","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanhee","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hwan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heung-Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"1377_CR1","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","volume":"18 Suppl 1","author":"EC Hirsch","year":"2012","unstructured":"Hirsch, E. C., Vyas, S. & Hunot, S. Neuroinflammation in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 18 Suppl 1, S210\u2013S212 (2012).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1377_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/ejn.14290","volume":"49","author":"MG Tansey","year":"2019","unstructured":"Tansey, M. G. & Romero-Ramos, M. Immune system responses in Parkinson\u2019s disease: Early and dynamic. Eur. J. Neurosci. 49, 364\u2013383 (2019).","journal-title":"Eur. J. Neurosci."},{"key":"1377_CR3","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard, V. et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Invest. 119, 182\u2013192 (2009).","journal-title":"J. Clin. Invest."},{"key":"1377_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","volume":"13","author":"K Lau","year":"2024","unstructured":"Lau, K., Kotzur, R. & Richter, F. Blood-brain barrier alterations and their impact on Parkinson\u2019s disease pathogenesis and therapy. Transl. Neurodegener. 13, 37 (2024).","journal-title":"Transl. Neurodegener."},{"key":"1377_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R. & Zlokovic, B. V. Blood-Brain Barrier: From Physiology to Disease and Back. Physiol. Rev. 99, 21\u201378 (2019).","journal-title":"Physiol. Rev."},{"key":"1377_CR6","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/mds.29122","volume":"37","author":"D Athauda","year":"2022","unstructured":"Athauda, D. et al. The Impact of Type 2 Diabetes in Parkinson\u2019s Disease. Mov. Disord. 37, 1612\u20131623 (2022).","journal-title":"Mov. Disord."},{"key":"1377_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.alit.2023.07.005","volume":"73","author":"JY Nam","year":"2024","unstructured":"Nam, J. Y. et al. Association of allergic disease with Parkinson\u2019s disease: A nationally representative retrospective cohort study. Allergol. Int. 73, 107\u2013114 (2024).","journal-title":"Allergol. Int."},{"key":"1377_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd4624","volume":"15","author":"NA Gandhi","year":"2016","unstructured":"Gandhi, N. A. et al. Targeting key proximal drivers of type 2 inflammation in disease. Nat. Rev. Drug Discov. 15, 35\u201350 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1377_CR9","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.jaip.2019.02.030","volume":"7","author":"M Humbert","year":"2019","unstructured":"Humbert, M. et al. IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy. J. Allergy Clin. Immunol. Pr. 7, 1418\u20131429 (2019).","journal-title":"J. Allergy Clin. Immunol. Pr."},{"key":"1377_CR10","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1067\/mai.2000.105712","volume":"105","author":"GJ Gleich","year":"2000","unstructured":"Gleich, G. J. Mechanisms of eosinophil-associated inflammation. J. Allergy Clin. Immunol. 105, 651\u2013663 (2000).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1377_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.clim.2016.09.010","volume":"189","author":"AK Huber","year":"2018","unstructured":"Huber, A. K., Giles, D. A., Segal, B. M. & Irani, D. N. An emerging role for eotaxins in neurodegenerative disease. Clin. Immunol. 189, 29\u201333 (2018).","journal-title":"Clin. Immunol."},{"key":"1377_CR12","doi-asserted-by":"publisher","first-page":"421389","DOI":"10.1155\/2013\/421389","volume":"2013","author":"GT Liu","year":"2013","unstructured":"Liu, G. T. et al. Eosinophil-derived neurotoxin is elevated in patients with amyotrophic lateral sclerosis. Mediators Inflamm. 2013, 421389 (2013).","journal-title":"Mediators Inflamm."},{"key":"1377_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev-immunol-082423-032154","volume":"43","author":"C Han","year":"2025","unstructured":"Han, C., Zhu, X. & Sokol, C. L. Neuroimmune Circuits in Allergic Diseases. Annu Rev. Immunol. 43, 367\u2013394 (2025).","journal-title":"Annu Rev. Immunol."},{"key":"1377_CR14","doi-asserted-by":"publisher","first-page":"eabi6887","DOI":"10.1126\/sciimmunol.abi6887","volume":"8","author":"MS Fassett","year":"2023","unstructured":"Fassett, M. S. et al. IL-31-dependent neurogenic inflammation restrains cutaneous type 2 immune response in allergic dermatitis. Sci. Immunol. 8, eabi6887 (2023).","journal-title":"Sci. Immunol."},{"key":"1377_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"1377_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fneur.2017.00037","volume":"8","author":"CD Rietdijk","year":"2017","unstructured":"Rietdijk, C. D., Perez-Pardo, P., Garssen, J., van Wezel, R. J. & Kraneveld, A. D. Exploring Braak\u2019s Hypothesis of Parkinson\u2019s Disease. Front. Neurol. 8, 37 (2017).","journal-title":"Front. Neurol."},{"key":"1377_CR17","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/brain\/awab005","volume":"144","author":"A Stefani","year":"2021","unstructured":"Stefani, A. et al. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder. Brain 144, 1118\u20131126 (2021).","journal-title":"Brain"},{"key":"1377_CR18","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/mds.22066","volume":"23","author":"A Lerner","year":"2008","unstructured":"Lerner, A. & Bagic, A. Olfactory pathogenesis of idiopathic Parkinson disease revisited. Mov. Disord. 23, 1076\u20131084 (2008).","journal-title":"Mov. Disord."},{"key":"1377_CR19","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/bpa.12886","volume":"30","author":"H Niu","year":"2020","unstructured":"Niu, H. et al. IL-1\u03b2\/IL-1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha-Synuclein pathology in the olfactory bulb, substantia nigra and striatum. Brain Pathol. 30, 1102\u20131118 (2020).","journal-title":"Brain Pathol."},{"key":"1377_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s12035-012-8267-8","volume":"47","author":"CM Lema Tom\u00e9","year":"2013","unstructured":"Lema Tom\u00e9, C. M. et al. Inflammation and \u03b1-synuclein\u2019s prion-like behavior in Parkinson\u2019s disease-is there a link? Mol. Neurobiol. 47, 561\u2013574 (2013).","journal-title":"Mol. Neurobiol."},{"key":"1377_CR21","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s12276-022-00895-w","volume":"54","author":"TK Kim","year":"2022","unstructured":"Kim, T. K. et al. Inflammation promotes synucleinopathy propagation. Exp. Mol. Med 54, 2148\u20132161 (2022).","journal-title":"Exp. Mol. Med"},{"key":"1377_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5415\/apallergy.2013.3.3.145","volume":"3","author":"SY Lee","year":"2013","unstructured":"Lee, S. Y., Chang, Y. S. & Cho, S. H. Allergic diseases and air pollution. Asia Pac. Allergy 3, 145\u2013154 (2013).","journal-title":"Asia Pac. Allergy"},{"key":"1377_CR23","doi-asserted-by":"publisher","first-page":"575330","DOI":"10.3389\/fpubh.2020.575330","volume":"8","author":"H Kim","year":"2020","unstructured":"Kim, H., Kim, W. H., Kim, Y. Y. & Park, H. Y. Air Pollution and Central Nervous System Disease: A Review of the Impact of Fine Particulate Matter on Neurological Disorders. Front Pub. Health 8, 575330 (2020).","journal-title":"Front Pub. Health"},{"key":"1377_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1515\/reveh-2017-0009","volume":"32","author":"N Palacios","year":"2017","unstructured":"Palacios, N. Air pollution and Parkinson\u2019s disease - evidence and future directions. Rev. Environ. Health 32, 303\u2013313 (2017).","journal-title":"Rev. Environ. Health"},{"key":"1377_CR25","doi-asserted-by":"publisher","first-page":"115565","DOI":"10.1016\/j.ecoenv.2023.115565","volume":"266","author":"J Lee","year":"2023","unstructured":"Lee, J. et al. Particulate matter exposure and neurodegenerative diseases: A comprehensive update on toxicity and mechanisms. Ecotoxicol. Environ. Saf. 266, 115565 (2023).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"1377_CR26","doi-asserted-by":"publisher","first-page":"e2433602","DOI":"10.1001\/jamanetworkopen.2024.33602","volume":"7","author":"B Krzyzanowski","year":"2024","unstructured":"Krzyzanowski, B. et al. Air Pollution and Parkinson Disease in a Population-Based Study. JAMA Netw. Open 7, e2433602 (2024).","journal-title":"JAMA Netw. Open"},{"key":"1377_CR27","doi-asserted-by":"crossref","unstructured":"Tandra, G., et al. Literature-Based Discovery Predicts Antihistamines Are a Promising Repurposed Adjuvant Therapy for Parkinson\u2019s Disease. Int. J. Mol. Sci. 24, 12339 (2023).","DOI":"10.3390\/ijms241512339"},{"key":"1377_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3233\/JPD-212769","volume":"12","author":"H Nawaz","year":"2022","unstructured":"Nawaz, H. et al. Anticholinergic Medication Burden in Parkinson\u2019s Disease Outpatients. J. Parkinsons Dis. 12, 599\u2013606 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"1377_CR29","doi-asserted-by":"publisher","first-page":"14772","DOI":"10.1021\/acsomega.2c00145","volume":"7","author":"M Ayaz","year":"2022","unstructured":"Ayaz, M. et al. Parkinsonism Attenuation by Antihistamines via Downregulating the Oxidative Stress, Histamine, and Inflammation. ACS Omega 7, 14772\u201314783 (2022).","journal-title":"ACS Omega"},{"key":"1377_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pbr.2021.06.003","volume":"266","author":"A Sharma","year":"2021","unstructured":"Sharma, A. et al. Histamine H3 and H4 receptors modulate Parkinson\u2019s disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy. Prog. Brain Res 266, 1\u201373 (2021).","journal-title":"Prog. Brain Res"},{"key":"1377_CR31","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/aje\/kwaa012","volume":"189","author":"F Giorgianni","year":"2020","unstructured":"Giorgianni, F., Ernst, P., Dell\u2019Aniello, S., Suissa, S. & Renoux, C. \u03b2 2-Agonists and the Incidence of Parkinson Disease. Am. J. Epidemiol. 189, 801\u2013810 (2020).","journal-title":"Am. J. Epidemiol."},{"key":"1377_CR32","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/mds.108","volume":"33","author":"N Gronich","year":"2018","unstructured":"Gronich, N. et al. 2-adrenoceptor agonists and antagonists and risk of Parkinson\u2019s disease. Mov. Disord. 33, 1465\u20131471 (2018).","journal-title":"Mov. Disord."},{"key":"1377_CR33","doi-asserted-by":"publisher","first-page":"103780","DOI":"10.1155\/2014\/103780","volume":"2014","author":"L Peterson","year":"2014","unstructured":"Peterson, L., Ismond, K. P., Chapman, E. & Flood, P. Potential benefits of therapeutic use of \u03b22-adrenergic receptor agonists in neuroprotection and Parkinson\u03bcs disease. J. Immunol. Res 2014, 103780 (2014).","journal-title":"J. Immunol. Res"},{"key":"1377_CR34","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/archneur.64.7.990","volume":"64","author":"B Ritz","year":"2007","unstructured":"Ritz, B. et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch. Neurol. 64, 990\u2013997 (2007).","journal-title":"Arch. Neurol."},{"key":"1377_CR35","doi-asserted-by":"publisher","first-page":"e2132","DOI":"10.1212\/WNL.0000000000009437","volume":"94","author":"B Mappin-Kasirer","year":"2020","unstructured":"Mappin-Kasirer, B. et al. Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors. Neurology 94, e2132\u2013e2138 (2020).","journal-title":"Neurology"},{"key":"1377_CR36","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1212\/WNL.0000000000000879","volume":"83","author":"B Ritz","year":"2014","unstructured":"Ritz, B., Lee, P. C., Lassen, C. F. & Arah, O. A. Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease. Neurology 83, 1396\u20131402 (2014).","journal-title":"Neurology"},{"key":"1377_CR37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M. G. et al. Inflammation and immune dysfunction in Parkinson disease. Nat. Rev. Immunol. 22, 657\u2013673 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1377_CR38","doi-asserted-by":"publisher","first-page":"484","DOI":"10.21215\/kjfp.2016.6.5.484","volume":"6","author":"JH Keum","year":"2016","unstructured":"Keum, J. H., Shin, J. Y. & Sohn, K. J. Socioeconomic Status and Allergic Rhinitis in Korean Adults: The 2010-2012 Korea National Health and Nutrition Examination Survey. Korean J. Fam. Pract. 6, 484\u2013488 (2016).","journal-title":"Korean J. Fam. Pract."},{"key":"1377_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43053-0","volume":"14","author":"CM Capelle","year":"2023","unstructured":"Capelle, C. M. et al. Early-to-mid stage idiopathic Parkinson\u2019s disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females. Nat. Commun. 14, 7461 (2023).","journal-title":"Nat. Commun."},{"key":"1377_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41531-023-00626-6","volume":"10","author":"SC Pike","year":"2024","unstructured":"Pike, S. C., Havrda, M., Gilli, F., Zhang, Z. & Salas, L. A. Immunological shifts during early-stage Parkinson\u2019s disease identified with DNA methylation data on longitudinally collected blood samples. NPJ Parkinsons Dis. 10, 21 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1377_CR41","doi-asserted-by":"publisher","first-page":"111188","DOI":"10.1016\/j.exger.2020.111188","volume":"144","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Principal component analysis of routine blood test results with Parkinson\u2019s disease: A case-control study. Exp. Gerontol. 144, 111188 (2021).","journal-title":"Exp. Gerontol."},{"key":"1377_CR42","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1073\/pnas.76.3.1443","volume":"76","author":"DT Durack","year":"1979","unstructured":"Durack, D. T., Sumi, S. M. & Klebanoff, S. J. Neurotoxicity of human eosinophils. Proc. Natl. Acad. Sci. USA 76, 1443\u20131447 (1979).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1377_CR43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jneuroim.2010.06.012","volume":"227","author":"S Navarro","year":"2010","unstructured":"Navarro, S., Boix, E., Cuchillo, C. M. & Nogu\u00e9s, M. V. Eosinophil-induced neurotoxicity: the role of eosinophil cationic protein\/RNase 3. J. Neuroimmunol. 227, 60\u201370 (2010).","journal-title":"J. Neuroimmunol."},{"key":"1377_CR44","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.fmre.2023.05.020","volume":"4","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Activation and polarization of striatal microglia and astrocytes are involved in bradykinesia and allodynia in early-stage parkinsonian mice. Fundam. Res 4, 806\u2013819 (2024).","journal-title":"Fundam. Res"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01377-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01377-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01377-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:03:01Z","timestamp":1783900981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01377-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1377"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01377-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.22541\/au.176112558.80453346\/v1","asserted-by":"object"}]},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}